Quantum Discovery
Quantum Discovery Labs is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue our own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and anti-cancer efficacy.
Quantum@linkedin.com
Contacts: office@q-pharm.com or comment any post on the site. You are welcome!
Quantum on Google+Categories
- absorbtion (3)
- active transport (2)
- ADME (4)
- antibiotics (2)
- antiviral (6)
- bioavailability (3)
- cancer (5)
- cardiotoxicity (1)
- collaboration (13)
- compound libraries (1)
- COPD (1)
- docking (13)
- drug design (8)
- drug discovery platform (1)
- druglikeness (4)
- false positive (3)
- flue (4)
- Generalized Born (15)
- GPCR (1)
- HERG (6)
- HIV (3)
- HIV-1 integrase (1)
- HSV (1)
- human neutrophil elastase (1)
- IC50 (18)
- inflammation (3)
- influenza (3)
- kinase (1)
- LD50 (2)
- logP (1)
- matrix proteins (2)
- mechanism of action exploration (2)
- MRDD (3)
- new therapeutic uses (1)
- oncology (4)
- openbabel (3)
- PDK1 (1)
- polar liquid (17)
- publications (12)
- q-Mol (1)
- QSAR (1)
- Quantum Software (11)
- RecA (1)
- scoring (1)
- selectivity (3)
- solvation energy (19)
- ss DNA (1)
- talk (5)
- toxicity (7)
- trombine (2)
- tuberculosis (4)
- Uncategorized (5)
- video (3)
- water (20)
Recent comments
- Vladimir Chupakhin on Solubility in water/DMSO prediction
- Nbarnes25 on Quantum Discovery Services
- New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1 on Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
- Anonymous on Water polarization and density profiles at a gas-liquid interface
- Anonymous on New inhibitors of RecA (bacterial SOS response system) identified.
collaboration Archive
-
Quantum announce collaboration with University of Colorado at Boulder
Posted on June 15, 2008 | No CommentsMoscow, July 15 2008 Quantum announce drug discovery collaboration with University of Colorado at Boulder. Under the terms of agreement Quantum will apply its state-of-the-art in-house drug discovery technology to... -
Quantum and Otechestvennye Lekarstva OJSC entered drug discovery collaboration.
Posted on March 25, 2008 | No Comments(Moscow, 25 March 2008) Quantum entered a collaboration with Otechestvennye Lekarstva OJSC. Under the terms of collaborative agreement Quantum will apply its proprietary technology to explore the mechanism of action... -
LEADFINDING.COM, ONLINE HIT-TO-LEAD OPTIMIZATION SERVICE
Posted on December 20, 2007 | No CommentsSan Diego, California – December 17th, 2007 – ChemDiv Inc (San Diego) and Quantum Pharmaceuticals (Moscow) announce the launch of LEADFINDING.COM, their powerful new internet-based hit-to-lead optimization service and online... -
EMD Serono, Inc licensed Quantum’ drug discovery technology.
Posted on December 10, 2007 | No CommentsMoscow, 10 December, 2007 EMD Serono, Inc entered license agreement with Quantum to get an access to Quantum’ small molecule hit identification computational platform and apply it in in-house research....